Posttransplant malignancy (Q35923812)

11 August 2017

1 reference

title

Posttransplant malignancy (English)

1 reference

11 August 2017

E Steve Woodle

1 reference

11 August 2017

Rita R Alloway

1 reference

11 August 2017

Joseph F Buell

1 reference

11 August 2017

Jennifer Trofe

1 reference

11 August 2017

Thomas M Beebe

1 reference

11 August 2017

Michael J Hanaway

1 reference

11 August 2017

M Roy First

1 reference

11 August 2017

Thomas G Gross

1 reference

11 August 2017

publication date

1 September 2004

1 reference

Progress in Transplantation: the journal for procurement and clinical transplant professionals

11 August 2017

published in

1 reference

11 August 2017

1 reference

11 August 2017

1 reference

11 August 2017

page(s)

193-200

1 reference

Cancer incidence in a kidney-transplanted population.

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.3.T7R41052414T1U20

Risk for tumor and other disease transmission by transplantation: a population-based study of unrecognized malignancies and other diseases in organ donors

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.3.T7R41052414T1U20

First report of the United Network for Organ Sharing Transplant Tumor Registry: donors with a history of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.3.T7R41052414T1U20

Transmission of donor cancer into cardiothoracic transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.3.T7R41052414T1U20

Donors with central nervous system malignancies: are they truly safe?

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.3.T7R41052414T1U20

Transplant tumor registry: donors with central nervous system tumors1.

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.3.T7R41052414T1U20

Risk of tumor transmission in transplantation from donors with primary brain tumors: an Australian and New Zealand registry report

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.3.T7R41052414T1U20

Skin cancers after organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.3.T7R41052414T1U20

Post-transplant malignancy: the role of immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.3.T7R41052414T1U20

Screening for Prostate, Breast and Colorectal Cancer in Renal Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.3.T7R41052414T1U20

Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.3.T7R41052414T1U20

Post-transplant lymphoproliferative disorder in the United States: young Caucasian males are at highest risk

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.3.T7R41052414T1U20

Posttransplantation lymphoproliferative disorder presenting as a unilateral leg mass 10 years after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.3.T7R41052414T1U20

Epstein-Barr virus and post-transplant lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.3.T7R41052414T1U20

Posttransplant viral syndromes in pediatric patients: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.3.T7R41052414T1U20

Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.3.T7R41052414T1U20

The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.3.T7R41052414T1U20

Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.3.T7R41052414T1U20

Is posttransplant lymphoproliferative disorder (PTLD) caused by any specific immunosuppressive drug or by the transplantation per se?

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.3.T7R41052414T1U20

Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.3.T7R41052414T1U20

Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.3.T7R41052414T1U20

Diagnosis and management of posttransplant lymphoproliferative disorder in solid-organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.3.T7R41052414T1U20

Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.3.T7R41052414T1U20

Lymphomas occurring late after solid-organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.7182%2FPRTR.14.3.T7R41052414T1U20

10.7182/PRTR.14.3.T7R41052414T1U20

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference